Duska Dragun is a full professor of medicine and nephrology at the Medical Faculty of Charité Universitätsmedizin Berlin and a chief attending of the Department for Nephrology and Critical Care Medicine, Charité Universitätsmedizin Berlin. Beside her clinical and research appointment, she is founder and the director of the Charité and Berlin Institute of Health Clinician Scientist Program supporting 120 clinician scientist fellows among all medical and surgical disciplines fostering translational biomedical research with structured molecular medicine curriculum and protected time for research.
Her research is dedicated to understand mechanisms of acute and chronic rejection organ transplant patients and to identify mechanisms to explain their therapy-refractory course. With combined approach of cohort studies in addition to careful phenotyping, she was able to discover new functional non-HLA antigens and to define new disease entities on the base of mechanistic differences on the level of receptor biology. One example is the introduction of the new concept of biased signaling via autoimmune activation of vascular GPCRs explaining severe pathologies in renal, heart, lung and liver transplants and autoimmune disease that fail to respond to classic immunomodulatory interventions.
She is recipient of numerous national and international awards in nephrology, cardiovascular and transplantation medicine for her research achievements as well as awards for her society engagement exemplified by “Germany - Land of Ideas” award for the BIH Charité Clinician Scientist Program.
During her career, she has published more than 140 articles in leading peer-reviewed journals including those in Cell and New England Journal of Medicine.
15:00 - 16:30
|Plenary Session — Lab Meets Clinical – Antibodies and Sensitization||Updates on non-HLA antibodies in SOT and the unmet needs for diagnostic testing||Bayshore D/E/F|